Health ❯ Healthcare ❯ Clinical Trials
Efficacy Studies Daraxonrasib MATTERHORN Trial Melanoma Research Efficacy and Safety Studies TULIP-SC Trial EMERALD-3 Trial Vaccine Efficacy Patient Outcomes Giredestrant Trials Survival Rates ASPEN Trial TROPION-Breast02 SERENA-6 Trial KALOS and LOGOS Trials KOMET Trial DESTINY-Breast05 Trial BOOG 2013-08 Trial University Research COMBI-AD Study Weight Loss Drugs EMBER-3 Trial HIMALAYA Trial Durvalumab Treatment Antibody-Drug Conjugates QDENGA Approval Lecanemab Studies CENTERSTONE Trial VERITAC-2 Trial lidERA Trial LidERA Trial SCORPIO-PEP Trial Retatrutide DREAMM-7 Trial OLIGUITO Study Cancer Treatment Efficacy inMIND Trial ARCHES and Related Studies Atezolizumab TROPION-Breast02 Trial ASPEN Study OBERON and TITANIA Trials Giredestrant Orforglipron Petrelintide LITESPARK-022 BRUIN CLL-321 Epioxa Trials Intismeran AMPLITUDE Study MOGAD IMforte Trial E-BEOND and C-BEOND Studies RASolute 302 OLYMPIA Trials TROPION-Breast01 Trial KEYNOTE-B96 Trial BaxHTN Trial GALAXI Trials Interlace Trial SAFFRON Trial ENZAMET Study HD21 Trial Trial Results DESTINY-Breast09 DESTINY-Breast Trials DUPLEX Study Serena-6 Trial Sovleplenib Drug Efficacy APPLAUSE-IgAN Study FRESCO-2 Trial Eli Lilly Trials NRG Oncology Trials BREAKWATER Trial QUASAR Trial Plozasiran Trials Vaccine Trials DESTINY-Lung04 Metastatic Cancer Trials REGENCY Study VISIONARY Trial Baxdrostat Trial Results POTOMAC Trial CROWN Trial I CAN Trial HERIZON-GEA-01 Trial Awiqli Approval ASCENT-07 Trial MDMA Trials ADVANCE-1 and ACCORD-2 Studies Cancer Treatment Studies ENPP1 Deficiency Treatments AMPLITUDE Trial CAPItello-281 SWIFT Trials OPTIMA Study Weight Loss Efficacy Immunological Response Aceclidine Studies
Want to see what podcasts are saying about this topic? Search across 140K+ podcasts. Explore Radar
The recommendation would allow adjuvant treatment for selected resected HER2‑positive early breast cancers while a European Commission decision and an updated product label are awaited.
